Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases
Proteomics and metabolomics are two emerging fields that hold promise to shine light on the molecular mechanisms causing neurodegenerative diseases. Research in this area may reveal and quantify specific metabolites and proteins that can be targeted by therapeutic interventions intended at halting o...
Main Authors: | Artur Schumacher-Schuh, Andrei Bieger, Wyllians V. Borelli, Makayla K. Portley, Paula Saffie Awad, Sara Bandres-Ciga |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.792227/full |
Similar Items
-
Advancing Personalized Medicine in Common Forms of Parkinson’s Disease through Genetics: Current Therapeutics and the Future of Individualized Management
by: Xylena Reed, et al.
Published: (2021-03-01) -
Proteotoxicity and Neurodegenerative Diseases
by: Clara Ruz, et al.
Published: (2020-08-01) -
Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead
by: Julie Lake, et al.
Published: (2021-04-01) -
Proteomic and metabolomic characterizations of moyamoya disease patient sera
by: Qingbao Guo, et al.
Published: (2023-12-01) -
The role of monogenic genes in idiopathic Parkinson’s disease
by: Xylena Reed, et al.
Published: (2019-04-01)